Wei-Jong Shia

Wei-Jong Shia has a strong background in protein purification and analytics for biotherapeutic development, with a focus on cancer treatment. They began their career as a Graduate Student at The Pennsylvania State University, where they conducted research until 2006. Following that, they worked as a Postdoc Fellow at The Scripps Research Institute from 2006 to 2008, and then at the University of California, San Diego from 2008 to 2012. At Polaris Pharmaceuticals, Wei-Jong held various roles, including Research Scientist from 2012 to 2014, Senior Scientist from 2014 to 2015, Principal Scientist from 2016 to 2021, and currently serves as a Senior Principal Scientist. Their work at Polaris Pharmaceuticals focused on protein purification and analytics for the development of arginine-depleting biotherapeutic leads for cancer treatment, as well as the purification of other proteins for biotherapeutics discovery-stage projects.

Wei-Jong Shia earned a Ph.D. in Biochemistry, Microbiology, and Molecular Biology from Penn State University, where they studied from 2000 to 2006. Prior to that, they completed their undergraduate studies at National Sun Yat-Sen University, earning a Bachelor of Science (BS) degree in Biology from 1993 to 1997.